Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Cook

Showing results (141-150 of 158) with videos related to

Pageof 16
Sort By:
Science Translational Medicine|August 2, 2023
Proregenerative extracellular matrix hydrogel mitigates pathological alterations of pelvic skeletal muscles after birth injuryPamela Duran, Francesca Boscolo Sesillo, Mark Cook, et al.
Haematologica|December 3, 2009
Factors predicting long-term survival after T-cell depleted reduced intensity allogeneic stem cell transplantation for acute myeloid leukemiaCharles Craddock, Sandeep Nagra, Andrew Peniket, et al.
Epilepsy & Behavior : E&B|February 24, 2026
The therapeutic effect of breathing interventions for functional seizures: A scoping reviewJade-Jocelyne Zouki, Hua Ye, Alfred Pak-Kwan Lo, et al.
Blood|January 12, 2012
Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML)Oliver C Goodyear, Mike Dennis, Nadira Y Jilani, et al.
Epilepsia|June 5, 2020
Signal quality and patient experience with wearable devices for epilepsy managementMona Nasseri, Ewan Nurse, Martin Glasstetter, et al.
BMJ Open|January 30, 2026
Breathing control training as a treatment for functional seizures (BREATHS trial): a multicentre, assessor-blinded, randomised controlled efficacy and acceptability trial study protocolRichard Kanaan, Rod Duncan, Cathrine Mihalopoulos, et al.
The Lancet. Haematology|September 9, 2024
Ixazomib as consolidation and maintenance versus observation in patients with relapsed multiple myeloma eligible for salvage autologous stem-cell transplantation (Myeloma XII [ACCoRD]): interim analysis of a multicentre, open-label, randomised, phase 3 trialGordon Cook, A John Ashcroft, Ethan Senior, et al.
The New England Journal of Medicine|February 10, 2023
Ide-cel or Standard Regimens in Relapsed and Refractory Multiple MyelomaPaula Rodriguez-Otero, Sikander Ailawadhi, Bertrand Arnulf, et al.
Future Oncology (London, England)|April 23, 2024
Plain language summary of the KarMMa-3 study of ide-cel or standard of care regimens in people with relapsed or refractory multiple myelomaPaula Rodriguez-Otero, Sikander Ailawadhi, Bertrand Arnulf, et al.
Haematologica|September 17, 2016
High-dose therapy and autologous stem cell transplantation in patients with POEMS syndrome: a retrospective study of the Plasma Cell Disorder sub-committee of the Chronic Malignancy Working Party of the European Society for Blood & Marrow TransplantationGordon Cook, Simona Iacobelli, Anja van Biezen, et al.
Pageof 16

Showing results (141-150 of 158) with videos related to

Sort By:
Pageof 16
Science Translational Medicine|August 2, 2023
Proregenerative extracellular matrix hydrogel mitigates pathological alterations of pelvic skeletal muscles after birth injuryPamela Duran, Francesca Boscolo Sesillo, Mark Cook, et al.
Haematologica|December 3, 2009
Factors predicting long-term survival after T-cell depleted reduced intensity allogeneic stem cell transplantation for acute myeloid leukemiaCharles Craddock, Sandeep Nagra, Andrew Peniket, et al.
Epilepsy & Behavior : E&B|February 24, 2026
The therapeutic effect of breathing interventions for functional seizures: A scoping reviewJade-Jocelyne Zouki, Hua Ye, Alfred Pak-Kwan Lo, et al.
Blood|January 12, 2012
Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML)Oliver C Goodyear, Mike Dennis, Nadira Y Jilani, et al.
Epilepsia|June 5, 2020
Signal quality and patient experience with wearable devices for epilepsy managementMona Nasseri, Ewan Nurse, Martin Glasstetter, et al.
BMJ Open|January 30, 2026
Breathing control training as a treatment for functional seizures (BREATHS trial): a multicentre, assessor-blinded, randomised controlled efficacy and acceptability trial study protocolRichard Kanaan, Rod Duncan, Cathrine Mihalopoulos, et al.
The Lancet. Haematology|September 9, 2024
Ixazomib as consolidation and maintenance versus observation in patients with relapsed multiple myeloma eligible for salvage autologous stem-cell transplantation (Myeloma XII [ACCoRD]): interim analysis of a multicentre, open-label, randomised, phase 3 trialGordon Cook, A John Ashcroft, Ethan Senior, et al.
The New England Journal of Medicine|February 10, 2023
Ide-cel or Standard Regimens in Relapsed and Refractory Multiple MyelomaPaula Rodriguez-Otero, Sikander Ailawadhi, Bertrand Arnulf, et al.
Future Oncology (London, England)|April 23, 2024
Plain language summary of the KarMMa-3 study of ide-cel or standard of care regimens in people with relapsed or refractory multiple myelomaPaula Rodriguez-Otero, Sikander Ailawadhi, Bertrand Arnulf, et al.
Haematologica|September 17, 2016
High-dose therapy and autologous stem cell transplantation in patients with POEMS syndrome: a retrospective study of the Plasma Cell Disorder sub-committee of the Chronic Malignancy Working Party of the European Society for Blood & Marrow TransplantationGordon Cook, Simona Iacobelli, Anja van Biezen, et al.
Pageof 16